The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
NCT ID: NCT06011681
Last Updated: 2024-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
960 participants
OBSERVATIONAL
2023-09-08
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurocognitive Outcomes of Depression in the Elderly
NCT00570583
Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive Impairment
NCT06780917
Emotional Cognition: Establishing Constructs and Neural-Behavioral Mechanisms in Older Adults With Depression
NCT05966532
A One-year Trajectory of Depression Status Changes in Older Adults With MCI and SD: a Longitudinal Cohort Study
NCT06308627
Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression
NCT00178087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Depression
Seniors diagnosed with late life depression or with a concern of late life depression.
No interventions assigned to this group
Mild cognitive impairment
Seniors with self-reported decline in cognitive function or with a diagnosis of mild cognitive impairment.
No interventions assigned to this group
Healthy controls
Seniors with no neurological or psychiatric symptoms or conditions.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MCI: Age 60 or over; diagnosis of MCI or self-reported insidious onset and continued worsening of cognitive decline; intact activities of daily living
* HC: Age 60 or over
Exclusion Criteria
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Miro Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shenly Glenn, BS
Role: PRINCIPAL_INVESTIGATOR
Miro Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Miro Health
Sacramento, California, United States
Miro Health
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
J o e l M e f f o r d, PHD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shenly Glenn
Role: primary
Shenly Glenn
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MH202206MCILLD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.